NYSE · CIK 0001716621
VJET Catheter Precision, Inc.
Insider trading from SEC Form 4. Last filing Mar 3, 2025. Close $1.14 on Oct 9, 2026, +23% from the 52-week low and -96% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
6
with a Form 4 at this company
Price and insider trades, last year
VJETOct 9, 2026 · close 1.14
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Catheter Precision, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | Martin J Colombatto director sell | $1 3 shares | -100% | - |
Transactions
The last 7 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 6, 2025 | Philip J Anderson Chief Financial Officer | AGrant or award Option (Right to Buy)derivative | +500,000 | $0.00 | $0 | 500,000 | Mar 3, 2025 |
| Jan 29, 2025 | Andrew Arno director | AGrant or award Stock Optionderivative | +100,000 | $0.00 | $0 | 100,000 | Jan 31, 2025 |
| Jan 29, 2025 | Martin J Colombatto director | SOpen-market sale Common Stockindirect: see footnote | -3 | $0.40 | $1 | 0 | Jan 31, 2025 |
| Jan 29, 2025 | James Joseph Caruso director | AGrant or award Stock Optionderivative | +100,000 | $0.00 | $0 | 100,000 | Jan 31, 2025 |
| Jan 29, 2025 | Marie-Claude Jacques Chief Commercial Officer | AGrant or award Stock Optionderivative | +125,000 | $0.00 | $0 | 125,000 | Jan 31, 2025 |
| Jan 29, 2025 | David A Jenkins Chairman of the Board and CEO | AGrant or award Stock Optionderivative | +450,000 | $0.00 | $0 | 450,000 | Jan 31, 2025 |
| Jan 29, 2025 | Martin J Colombatto director | AGrant or award Stock Optionderivative | +100,000 | $0.00 | $0 | 100,000 | Jan 31, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Philip J AndersonChief Financial Officer
- Andrew Arnodirector
- Martin J Colombattodirector
- James Joseph Carusodirector
- David A JenkinsChairman of the Board and CEO
- Marie-Claude JacquesChief Commercial Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.